Thomas K E, Greenwood L, Murrant N, Cook J, Devalia J L, Davies R J
Department of Respiratory Medicine, St Bartholomew's Hospital, West Smithfield, London, U.K.
Respir Med. 1990 Nov;84 Suppl A:33-5. doi: 10.1016/s0954-6111(08)80006-6.
Nasal application of grass pollen allergen in atopic individuals with seasonal rhinitis leads to an early rise in nasal airways resistance. The effects of fluticasone propionate, a powerful, topically active glucocorticosteroid, on nasal airways resistance and cellular infiltration of the nasal mucous membrane were investigated. Fluticasone propionate blunted the rise in nasal airway resistance following allergen challenge (P = 0.089). Although this glucocorticosteroid did not affect the total number of eosinophils in biopsies of nasal mucous membrane, the number of activated eosinophils was significantly reduced (P less than 0.05).